vs

Side-by-side financial comparison of BLACKBERRY Ltd (BB) and Vericel Corp (VCEL). Click either name above to swap in a different company.

BLACKBERRY Ltd is the larger business by last-quarter revenue ($141.8M vs $92.9M, roughly 1.5× Vericel Corp). Vericel Corp runs the higher net margin — 25.0% vs 9.7%, a 15.4% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs -0.8%). BLACKBERRY Ltd produced more free cash flow last quarter ($17.4M vs $12.8M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 17.8%).

BlackBerry Limited, formerly Research In Motion (RIM), is a Canadian software company specializing in secure communications and the Internet of Things (IoT). Founded in 1984, it developed the BlackBerry brand of two-way pagers, smartphones, and tablets. The company later transitioned to providing software and services and holds critical software application patents.

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.

BB vs VCEL — Head-to-Head

Bigger by revenue
BB
BB
1.5× larger
BB
$141.8M
$92.9M
VCEL
Growing faster (revenue YoY)
VCEL
VCEL
+24.1% gap
VCEL
23.3%
-0.8%
BB
Higher net margin
VCEL
VCEL
15.4% more per $
VCEL
25.0%
9.7%
BB
More free cash flow
BB
BB
$4.6M more FCF
BB
$17.4M
$12.8M
VCEL
Faster 2-yr revenue CAGR
VCEL
VCEL
Annualised
VCEL
34.6%
17.8%
BB

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
BB
BB
VCEL
VCEL
Revenue
$141.8M
$92.9M
Net Profit
$13.7M
$23.2M
Gross Margin
77.5%
78.7%
Operating Margin
8.4%
24.1%
Net Margin
9.7%
25.0%
Revenue YoY
-0.8%
23.3%
Net Profit YoY
224.5%
17.3%
EPS (diluted)
$0.02
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BB
BB
VCEL
VCEL
Q4 25
$141.8M
$92.9M
Q3 25
$129.6M
$67.5M
Q2 25
$121.7M
$63.2M
Q1 25
$141.7M
$52.6M
Q4 24
$143.6M
$75.4M
Q3 24
$126.2M
$57.9M
Q2 24
$123.4M
$52.7M
Q1 24
$102.1M
$51.3M
Net Profit
BB
BB
VCEL
VCEL
Q4 25
$13.7M
$23.2M
Q3 25
$13.3M
$5.1M
Q2 25
$1.9M
$-553.0K
Q1 25
$-7.4M
$-11.2M
Q4 24
$-10.5M
$19.8M
Q3 24
$-19.7M
$-901.0K
Q2 24
$-41.4M
$-4.7M
Q1 24
$-56.2M
$-3.9M
Gross Margin
BB
BB
VCEL
VCEL
Q4 25
77.5%
78.7%
Q3 25
74.5%
73.5%
Q2 25
74.2%
73.7%
Q1 25
73.5%
69.0%
Q4 24
78.1%
77.6%
Q3 24
70.2%
71.9%
Q2 24
72.9%
69.5%
Q1 24
68.9%
Operating Margin
BB
BB
VCEL
VCEL
Q4 25
8.4%
24.1%
Q3 25
8.9%
5.1%
Q2 25
1.6%
-3.2%
Q1 25
-5.6%
-24.3%
Q4 24
13.6%
24.5%
Q3 24
1.7%
-4.3%
Q2 24
-10.5%
-11.5%
Q1 24
50.0%
-10.7%
Net Margin
BB
BB
VCEL
VCEL
Q4 25
9.7%
25.0%
Q3 25
10.3%
7.5%
Q2 25
1.6%
-0.9%
Q1 25
-5.2%
-21.4%
Q4 24
-7.3%
26.3%
Q3 24
-15.6%
-1.6%
Q2 24
-33.5%
-8.9%
Q1 24
-55.0%
-7.5%
EPS (diluted)
BB
BB
VCEL
VCEL
Q4 25
$0.02
$0.46
Q3 25
$0.02
$0.10
Q2 25
$0.00
$-0.01
Q1 25
$-0.01
$-0.23
Q4 24
$-0.02
$0.40
Q3 24
$-0.03
$-0.02
Q2 24
$-0.07
$-0.10
Q1 24
$-0.08
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BB
BB
VCEL
VCEL
Cash + ST InvestmentsLiquidity on hand
$304.2M
$137.5M
Total DebtLower is stronger
$196.2M
Stockholders' EquityBook value
$741.1M
$354.6M
Total Assets
$1.2B
$488.0M
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BB
BB
VCEL
VCEL
Q4 25
$304.2M
$137.5M
Q3 25
$290.5M
$135.4M
Q2 25
$306.6M
$116.9M
Q1 25
$337.8M
$112.9M
Q4 24
$220.0M
$116.2M
Q3 24
$211.0M
$101.7M
Q2 24
$229.0M
$102.5M
Q1 24
$237.1M
$110.6M
Total Debt
BB
BB
VCEL
VCEL
Q4 25
$196.2M
Q3 25
$195.9M
Q2 25
$195.6M
Q1 25
$195.3M
Q4 24
Q3 24
Q2 24
Q1 24
$194.1M
Stockholders' Equity
BB
BB
VCEL
VCEL
Q4 25
$741.1M
$354.6M
Q3 25
$725.1M
$321.9M
Q2 25
$725.1M
$306.8M
Q1 25
$719.9M
$295.5M
Q4 24
$725.2M
$292.0M
Q3 24
$732.1M
$257.5M
Q2 24
$742.6M
$243.0M
Q1 24
$775.1M
$233.9M
Total Assets
BB
BB
VCEL
VCEL
Q4 25
$1.2B
$488.0M
Q3 25
$1.2B
$453.3M
Q2 25
$1.2B
$435.6M
Q1 25
$1.3B
$424.6M
Q4 24
$1.3B
$432.7M
Q3 24
$1.3B
$390.4M
Q2 24
$1.3B
$376.8M
Q1 24
$1.4B
$356.7M
Debt / Equity
BB
BB
VCEL
VCEL
Q4 25
0.26×
Q3 25
0.27×
Q2 25
0.27×
Q1 25
0.27×
Q4 24
Q3 24
Q2 24
Q1 24
0.25×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BB
BB
VCEL
VCEL
Operating Cash FlowLast quarter
$18.3M
$15.0M
Free Cash FlowOCF − Capex
$17.4M
$12.8M
FCF MarginFCF / Revenue
12.3%
13.8%
Capex IntensityCapex / Revenue
0.6%
2.4%
Cash ConversionOCF / Net Profit
1.34×
0.65×
TTM Free Cash FlowTrailing 4 quarters
$42.8M
$24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BB
BB
VCEL
VCEL
Q4 25
$18.3M
$15.0M
Q3 25
$3.9M
$22.1M
Q2 25
$-18.0M
$8.2M
Q1 25
$41.6M
$6.6M
Q4 24
$6.0M
$22.2M
Q3 24
$-16.0M
$10.2M
Q2 24
$-15.1M
$18.5M
Q1 24
$-15.5M
$7.2M
Free Cash Flow
BB
BB
VCEL
VCEL
Q4 25
$17.4M
$12.8M
Q3 25
$3.1M
$19.5M
Q2 25
$-18.9M
$81.0K
Q1 25
$41.2M
$-7.6M
Q4 24
$5.2M
$8.5M
Q3 24
$-16.5M
$-9.2M
Q2 24
$-16.5M
$1.8M
Q1 24
$-17.6M
$-6.8M
FCF Margin
BB
BB
VCEL
VCEL
Q4 25
12.3%
13.8%
Q3 25
2.4%
28.8%
Q2 25
-15.5%
0.1%
Q1 25
29.1%
-14.5%
Q4 24
3.6%
11.2%
Q3 24
-13.1%
-15.9%
Q2 24
-13.4%
3.4%
Q1 24
-17.2%
-13.3%
Capex Intensity
BB
BB
VCEL
VCEL
Q4 25
0.6%
2.4%
Q3 25
0.6%
3.9%
Q2 25
0.7%
12.9%
Q1 25
0.3%
27.0%
Q4 24
0.6%
18.3%
Q3 24
0.4%
33.5%
Q2 24
1.1%
31.8%
Q1 24
2.1%
27.3%
Cash Conversion
BB
BB
VCEL
VCEL
Q4 25
1.34×
0.65×
Q3 25
0.29×
4.35×
Q2 25
-9.47×
Q1 25
Q4 24
1.12×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BB
BB

QNX$68.7M48%
Secure Communication$67.0M47%
Licensing$6.1M4%

VCEL
VCEL

MACI Implants And Kits$84.1M90%
Other$8.8M10%

Related Comparisons